文献速递外周动脉疾病

逆行动脉入路用于严重肢体缺血腔内治疗的安全性与有效性

Safety and Effectiveness of Retrograde Arterial Access for Endovascular Treatment of Critical Limb Ischemia.
PubMed 文献 · Ann Vasc Surg · 2018-09-11

该回顾性研究分析了2012年2月至2017年12月接受外周血管介入的566例严重肢体缺血患者,其中26例(4.6%)采用逆行动脉入路。逆行进路技术成功率为96.2%,无远端栓塞、穿孔或远端靶血管丢失,但一期、一期辅助和二期通畅率以及保肢率和无截肢生存率均低于顺行入路,总生存率无差异。作者认为逆行进路是顺行入路失败时可行且安全的选择。

要点

  • 逆行进路技术成功率为96.2%,无远端栓塞、穿孔或远端靶血管丢失。
  • 逆行进路患者的一期、一期辅助和二期通畅率、保肢率及无截肢生存率均低于顺行入路。
  • 逆行进路与顺行入路的总生存率无差异,作者认为顺行入路失败时逆行进路是可行且安全的选择。

核心结论

  • 作者认为逆行动脉入路是顺行入路失败时可行且安全的血运重建选择,尽管结局劣于顺行入路,但在严重肢体缺血患者中尤其当开放手术血运重建不是选项时可能有用。

研究设计与样本

  • 回顾性审查前瞻性收集的机构数据(连续M2S录入),纳入2012年2月至2017年12月接受外周血管介入的严重肢体缺血患者,比较逆行动脉入路与标准顺行入路患者的结局。

主要发现

  • 共识别566例患者,其中26例(4.6%)接受逆行动脉入路。
  • 逆行进路中,4例经腘动脉(15.4%),13例经踝上胫血管(50.0%),9例经足部血管(34.6%)。
  • 逆行进路技术成功率为96.2%,无远端栓塞、穿孔或远端靶血管丢失发生。
  • 逆行进路患者的一期、一期辅助和二期通畅率以及保肢率和无截肢生存率均持续低于顺行入路患者。
  • 逆行进路与顺行入路的总生存率无差异。

临床怎么用

  • 作者认为逆行动脉入路是顺行入路失败时可行且安全的血运重建选择,尤其当开放手术血运重建不是选项时可能有用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Retrograde arterial access (RA) of the popliteal, tibial, or pedal arteries may facilitate endovascular treatment of complex infrainguinal lesions in patients with critical limb ischemia (CLI). Here, we assess the safety and efficacy of this technique. METHODS: A retrospective review of prospectively collected institutional data (consecutive M2S entries) was performed to identify patients with CLI undergoing peripheral vascular intervention from February 2012 through December 2017. Demographics, comorbidities, procedural characteristics, and outcomes were analyzed, and comparisons were made between outcomes of patients undergoing RA and those undergoing a standard antegrade access (SA) approach. RESULTS: Five hundred sixty-six patients were identified, of whom 26 (4.6%) underwent RA. Of these, 4 were accessed via the popliteal artery (15.4%), 13 via the tibial vessels above the ankle (50.0%), and 9 via pedal vessels (34.6%). RA facilitated procedural success in 96.2% of cases. There were no instances of distal embolization, perforation, or loss of distal target with RA. Primary, primary assisted, and secondary patency rates were consistently lower for RA patients than for SA patients, as was limb salvage and amputation-free survival. No difference was seen in overall survival. CONCLUSIONS: RA represents a viable and safe option for revascularization when SA fails. Although outcomes are poorer than SA, this technique can be useful in CLI patients, especially when open surgical revascularization is not an option.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Stern JR, Cafasso DE, Connolly PH, et al. Safety and Effectiveness of Retrograde Arterial Access for Endovascular Treatment of Critical Limb Ischemia. Ann Vasc Surg. 2018. PMID: 30217705. doi:10.1016/j.avsg.2018.08.072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。